# OnCo record capp2 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/capp2/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "capp2", "ISRCTN59521990" ;
  schema:name "CAPP2"@en ;
  schema:alternateName "CAPP 2"@en, "Colorectal Adenoma/Carcinoma Prevention Programme 2"@en ;
  schema:description "CAPP2 followed people with Lynch syndrome, an inherited condition that carries a very high risk of bowel cancer, for ten years after two to four years on aspirin or placebo: those who took aspirin developed about a third fewer bowel cancers, which is why daily aspirin is now offered to people with the syndrome."@en ;
  schema:url <https://onco.cc/trials/capp2/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://www.isrctn.com/ISRCTN59521990> ;
  onco:status "positive" ;
  onco:tag "soc-trials" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/msi-high-colorectal/> ;
  onco:technologies <https://onco.cc/technologies/aspirin-cancer-prevention/> ;
  onco:drugs <https://onco.cc/drugs/aspirin/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-capp2-aspirin-lynch-syndrome-10-year-burn-lancet-2020/> .